Contact

Our portfolio

Inreda Diabetic

Developing a bi-hormonal artificial pancreas, Inreda Diabetic offers a closed-loop system for diabetes management. Their device automates insulin and glucagon administration, drastically reducing the burden on patients compared to classic single-hormone pumps. Inreda Diabetic’s technology aims to improve blood glucose control and quality of life for diabetes patients.

  • Institute: Amsterdam UMC
Industry: Diabetes, Medical Technology
  • Founding year: 2007
Visit website

Want to get in contact about Inreda Diabetic?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
SusPhos
Upcycling phosphate waste into sustainable industrial products.
Kepler Vision Technologies
Improving elderly care with Night Nurse, an AI-powered patient monitoring system.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
SusPhos
Upcycling phosphate waste into sustainable industrial products.
Kepler Vision Technologies
Improving elderly care with Night Nurse, an AI-powered patient monitoring system.
Explore full AAV portfolio
Contact